This report contains market size and forecasts of Commercializing Biomarkers in global, including the following market information:
Global Commercializing Biomarkers Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Commercializing Biomarkers Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Commercializing Biomarkers companies in 2020 (%)
The global Commercializing Biomarkers market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Commercializing Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Commercializing Biomarkers Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Commercializing Biomarkers Market Segment Percentages, By Type, 2020 (%)
Consumables
Services
Software
Global Commercializing Biomarkers Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Commercializing Biomarkers Market Segment Percentages, By Application, 2020 (%)
Oncology
Cardiology
Neurology
Others
Global Commercializing Biomarkers Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Commercializing Biomarkers Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Commercializing Biomarkers revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Commercializing Biomarkers revenues share in global market, 2020 (%)
Key companies Commercializing Biomarkers sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Commercializing Biomarkers sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Commercializing Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Commercializing Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Commercializing Biomarkers Overall Market Size
2.1 Global Commercializing Biomarkers Market Size: 2021 VS 2027
2.2 Global Commercializing Biomarkers Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Commercializing Biomarkers Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Commercializing Biomarkers Players in Global Market
3.2 Top Global Commercializing Biomarkers Companies Ranked by Revenue
3.3 Global Commercializing Biomarkers Revenue by Companies
3.4 Global Commercializing Biomarkers Sales by Companies
3.5 Global Commercializing Biomarkers Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Commercializing Biomarkers Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Commercializing Biomarkers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Commercializing Biomarkers Players in Global Market
3.8.1 List of Global Tier 1 Commercializing Biomarkers Companies
3.8.2 List of Global Tier 2 and Tier 3 Commercializing Biomarkers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Commercializing Biomarkers Market Size Markets, 2021 & 2027
4.1.2 Consumables
4.1.3 Services
4.1.4 Software
4.2 By Type - Global Commercializing Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Commercializing Biomarkers Revenue, 2016-2021
4.2.2 By Type - Global Commercializing Biomarkers Revenue, 2022-2027
4.2.3 By Type - Global Commercializing Biomarkers Revenue Market Share, 2016-2027
4.3 By Type - Global Commercializing Biomarkers Sales & Forecasts
4.3.1 By Type - Global Commercializing Biomarkers Sales, 2016-2021
4.3.2 By Type - Global Commercializing Biomarkers Sales, 2022-2027
4.3.3 By Type - Global Commercializing Biomarkers Sales Market Share, 2016-2027
4.4 By Type - Global Commercializing Biomarkers Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Commercializing Biomarkers Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Neurology
5.1.5 Others
5.2 By Application - Global Commercializing Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Commercializing Biomarkers Revenue, 2016-2021
5.2.2 By Application - Global Commercializing Biomarkers Revenue, 2022-2027
5.2.3 By Application - Global Commercializing Biomarkers Revenue Market Share, 2016-2027
5.3 By Application - Global Commercializing Biomarkers Sales & Forecasts
5.3.1 By Application - Global Commercializing Biomarkers Sales, 2016-2021
5.3.2 By Application - Global Commercializing Biomarkers Sales, 2022-2027
5.3.3 By Application - Global Commercializing Biomarkers Sales Market Share, 2016-2027
5.4 By Application - Global Commercializing Biomarkers Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Commercializing Biomarkers Market Size, 2021 & 2027
6.2 By Region - Global Commercializing Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Commercializing Biomarkers Revenue, 2016-2021
6.2.2 By Region - Global Commercializing Biomarkers Revenue, 2022-2027
6.2.3 By Region - Global Commercializing Biomarkers Revenue Market Share, 2016-2027
6.3 By Region - Global Commercializing Biomarkers Sales & Forecasts
6.3.1 By Region - Global Commercializing Biomarkers Sales, 2016-2021
6.3.2 By Region - Global Commercializing Biomarkers Sales, 2022-2027
6.3.3 By Region - Global Commercializing Biomarkers Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Commercializing Biomarkers Revenue, 2016-2027
6.4.2 By Country - North America Commercializing Biomarkers Sales, 2016-2027
6.4.3 US Commercializing Biomarkers Market Size, 2016-2027
6.4.4 Canada Commercializing Biomarkers Market Size, 2016-2027
6.4.5 Mexico Commercializing Biomarkers Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Commercializing Biomarkers Revenue, 2016-2027
6.5.2 By Country - Europe Commercializing Biomarkers Sales, 2016-2027
6.5.3 Germany Commercializing Biomarkers Market Size, 2016-2027
6.5.4 France Commercializing Biomarkers Market Size, 2016-2027
6.5.5 U.K. Commercializing Biomarkers Market Size, 2016-2027
6.5.6 Italy Commercializing Biomarkers Market Size, 2016-2027
6.5.7 Russia Commercializing Biomarkers Market Size, 2016-2027
6.5.8 Nordic Countries Commercializing Biomarkers Market Size, 2016-2027
6.5.9 Benelux Commercializing Biomarkers Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Commercializing Biomarkers Revenue, 2016-2027
6.6.2 By Region - Asia Commercializing Biomarkers Sales, 2016-2027
6.6.3 China Commercializing Biomarkers Market Size, 2016-2027
6.6.4 Japan Commercializing Biomarkers Market Size, 2016-2027
6.6.5 South Korea Commercializing Biomarkers Market Size, 2016-2027
6.6.6 Southeast Asia Commercializing Biomarkers Market Size, 2016-2027
6.6.7 India Commercializing Biomarkers Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Commercializing Biomarkers Revenue, 2016-2027
6.7.2 By Country - South America Commercializing Biomarkers Sales, 2016-2027
6.7.3 Brazil Commercializing Biomarkers Market Size, 2016-2027
6.7.4 Argentina Commercializing Biomarkers Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Commercializing Biomarkers Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Commercializing Biomarkers Sales, 2016-2027
6.8.3 Turkey Commercializing Biomarkers Market Size, 2016-2027
6.8.4 Israel Commercializing Biomarkers Market Size, 2016-2027
6.8.5 Saudi Arabia Commercializing Biomarkers Market Size, 2016-2027
6.8.6 UAE Commercializing Biomarkers Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Commercializing Biomarkers Major Product Offerings
7.1.4 Roche Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Dako (Agilent Technologies)
7.2.1 Dako (Agilent Technologies) Corporate Summary
7.2.2 Dako (Agilent Technologies) Business Overview
7.2.3 Dako (Agilent Technologies) Commercializing Biomarkers Major Product Offerings
7.2.4 Dako (Agilent Technologies) Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.2.5 Dako (Agilent Technologies) Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Commercializing Biomarkers Major Product Offerings
7.3.4 Merck Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.3.5 Merck Key News
7.4 BD
7.4.1 BD Corporate Summary
7.4.2 BD Business Overview
7.4.3 BD Commercializing Biomarkers Major Product Offerings
7.4.4 BD Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.4.5 BD Key News
7.5 Abbott
7.5.1 Abbott Corporate Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Commercializing Biomarkers Major Product Offerings
7.5.4 Abbott Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.5.5 Abbott Key News
7.6 Genesys Biolabs (20/20GeneSystems)
7.6.1 Genesys Biolabs (20/20GeneSystems) Corporate Summary
7.6.2 Genesys Biolabs (20/20GeneSystems) Business Overview
7.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Major Product Offerings
7.6.4 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.6.5 Genesys Biolabs (20/20GeneSystems) Key News
7.7 Affymetrix
7.7.1 Affymetrix Corporate Summary
7.7.2 Affymetrix Business Overview
7.7.3 Affymetrix Commercializing Biomarkers Major Product Offerings
7.4.4 Affymetrix Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.7.5 Affymetrix Key News
7.8 Agendia
7.8.1 Agendia Corporate Summary
7.8.2 Agendia Business Overview
7.8.3 Agendia Commercializing Biomarkers Major Product Offerings
7.8.4 Agendia Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.8.5 Agendia Key News
7.9 ALMAC
7.9.1 ALMAC Corporate Summary
7.9.2 ALMAC Business Overview
7.9.3 ALMAC Commercializing Biomarkers Major Product Offerings
7.9.4 ALMAC Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.9.5 ALMAC Key News
7.10 Arrayit
7.10.1 Arrayit Corporate Summary
7.10.2 Arrayit Business Overview
7.10.3 Arrayit Commercializing Biomarkers Major Product Offerings
7.10.4 Arrayit Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.10.5 Arrayit Key News
7.11 Biocartic
7.11.1 Biocartic Corporate Summary
7.11.2 Biocartic Commercializing Biomarkers Business Overview
7.11.3 Biocartic Commercializing Biomarkers Major Product Offerings
7.11.4 Biocartic Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.11.5 Biocartic Key News
7.12 BG Medicine
7.12.1 BG Medicine Corporate Summary
7.12.2 BG Medicine Commercializing Biomarkers Business Overview
7.12.3 BG Medicine Commercializing Biomarkers Major Product Offerings
7.12.4 BG Medicine Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.12.5 BG Medicine Key News
7.13 KEGG EXPRESSION Database
7.13.1 KEGG EXPRESSION Database Corporate Summary
7.13.2 KEGG EXPRESSION Database Commercializing Biomarkers Business Overview
7.13.3 KEGG EXPRESSION Database Commercializing Biomarkers Major Product Offerings
7.13.4 KEGG EXPRESSION Database Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.13.5 KEGG EXPRESSION Database Key News
7.14 Thermo Fisher
7.14.1 Thermo Fisher Corporate Summary
7.14.2 Thermo Fisher Business Overview
7.14.3 Thermo Fisher Commercializing Biomarkers Major Product Offerings
7.14.4 Thermo Fisher Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.14.5 Thermo Fisher Key News
7.15 BGI
7.15.1 BGI Corporate Summary
7.15.2 BGI Business Overview
7.15.3 BGI Commercializing Biomarkers Major Product Offerings
7.15.4 BGI Commercializing Biomarkers Sales and Revenue in Global (2016-2021)
7.15.5 BGI Key News
8 Global Commercializing Biomarkers Production Capacity, Analysis
8.1 Global Commercializing Biomarkers Production Capacity, 2016-2027
8.2 Commercializing Biomarkers Production Capacity of Key Manufacturers in Global Market
8.3 Global Commercializing Biomarkers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Commercializing Biomarkers Supply Chain Analysis
10.1 Commercializing Biomarkers Industry Value Chain
10.2 Commercializing Biomarkers Upstream Market
10.3 Commercializing Biomarkers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Commercializing Biomarkers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Commercializing Biomarkers in Global Market
Table 2. Top Commercializing Biomarkers Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Commercializing Biomarkers Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Commercializing Biomarkers Revenue Share by Companies, 2016-2021
Table 5. Global Commercializing Biomarkers Sales by Companies, (K MT), 2016-2021
Table 6. Global Commercializing Biomarkers Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Commercializing Biomarkers Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Commercializing Biomarkers Product Type
Table 9. List of Global Tier 1 Commercializing Biomarkers Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Commercializing Biomarkers Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI